Skip to main content
. 2019 Nov 14;2:414. doi: 10.1038/s42003-019-0666-1

Fig. 2.

Fig. 2

Kaplan–Meier curve of the disease-free survival periods (a) and overall survival periods (b) of TCGA patients afflicted by the HM (high metabolic gene alteration frequencies) and LM (low metabolic gene alteration frequencies) cancer supertypes. c Kaplan–Meier curve of the overall survival periods of ICGC patients afflicted by the HM and LM cancer supertypes